Neuronetics, Inc. (STIM)

Healthcare · Medical Devices · Price $2.84
Updated: Aug 31, 2026
Revenue (TTM)
$155.1M
Trailing 12 Months
Growth Rate
32.81%
Log-Linear Regression (16Q)
Price/Sales
1.3x
Valuation Multiple
Revenue Per Share
$2.12
Sales / Shares
Gross Margin
49.12%
Pricing Power

📈 Revenue History (16 Quarters)

🧮 STIM Revenue Breakdown

Revenue = Product Sales + Service Revenue + Other Income
Total Revenue (TTM) $155.1M
Less: Cost of Revenue $78.9M
Equals: Gross Profit $76.2M
Then: Operating Income $-22.9M
Finally: Net Income $-30.4M

Understanding Revenue

Revenue, also called sales or the "top line," represents the total income a company generates from its business activities before any costs are deducted. For STIM, the trailing twelve month revenue is $155.1M.

Why Revenue Matters

Revenue is the foundation of all financial analysis. A company cannot have sustainable profits without revenue, and revenue growth often drives stock price appreciation. However, revenue alone doesn't tell the full story - it must be analyzed alongside profitability metrics.

STIM's revenue growth rate of 32.81% (based on log-linear regression of 16 quarters) indicates strong growth, typical of high-growth companies.

Revenue vs Profitability Metrics

Free Cash Flow: $-13.6M →

The cash remaining after capital expenditures. High revenue with negative FCF may indicate heavy reinvestment or poor cash conversion.

Owner Earnings: $-13.6M →

Buffett's metric for true cash generation. Compares revenue's conversion to actual owner value.

Earnings Per Share: $-0.44 →

Net income per share. The bottom line result of all revenue after costs, taxes, and interest.

Net Income: $-30.4M

What remains after all expenses. Net margin shows what percentage of revenue becomes profit.

Price/Sales Ratio Analysis

STIM's P/S ratio of 1.3x means investors pay $1.34 for every $1 of annual revenue. A P/S between 1-3 is typical for mature companies with moderate growth.

Gross Margin: Revenue Quality

Gross margin of 49.12% shows how much of STIM's revenue remains after direct costs. Gross margins between 40-60% are solid and typical of differentiated businesses.

Summary: STIM Revenue Trend

Neuronetics, Inc. (STIM) generated $155.1M in trailing twelve-month revenue, growing at 32.81% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses. Neuronetics, Inc.'s gross margin of 49.12% is good for a Healthcare company — above the 40% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins, reflecting solid product economics. For complete financial analysis, view the full STIM stock report on Zyberno.

Frequently Asked Questions

What is STIM's current revenue?

Neuronetics, Inc.'s trailing twelve month (TTM) revenue is $155.1M, growing at 32.81% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses.

Is STIM's revenue growing?

Neuronetics, Inc. (STIM) generated $155.1M in trailing twelve-month revenue, growing at 32.81% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses. Neuronetics, Inc.'s gross margin of 49.12% is good for a Healthcare company — above the 40% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins, reflecting solid product economics.

What is STIM's gross margin?

Neuronetics, Inc.'s gross margin of 49.12% is good for a Healthcare company — above the 40% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins, reflecting solid product economics.

What is STIM's Price/Sales ratio?

STIM's P/S ratio is 1.3x, meaning the market values the company at 1.3 times its annual revenue.

How does revenue differ from profit?

Revenue is the total income before any expenses, while profit (net income) is what remains after all costs. STIM's revenue is $155.1M with a net income of $-30.4M, showing a net profit margin of -19.6%.

📊 Valuation Trilogy
Three interconnected metrics built on Owner Earnings
💎
Intrinsic Value
DCF Fair Value
🛡️
Margin of Safety
Valuation Gap
🎯
Expected Return
Projected Annual
Click any metric for full methodology and detailed analysis

📊 Full STIM Stock Report

See STIM's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.

💵 STIM Free Cash Flow

Compare to Free Cash Flow which subtracts all capital expenditures, not just maintenance CapEx.

💰 STIM Owner Earnings

Compare to Buffett's Owner Earnings metric which uses maintenance CapEx instead of total capital expenditures.

📈 STIM Earnings Per Share

Analyze EPS trends, P/E ratio, earnings yield, and per-share profitability metrics.

🎯 STIM Earnings Surprise (SUE)

See whether STIM is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.

📊 STIM Revenue

Analyze revenue trends, growth rate, P/S ratio, and top-line sales performance.

💰 STIM Net Income

Analyze the bottom-line profit, P/E ratio, and net profit margin trends.

🔶 STIM Operating Income

Analyze EBIT, operating margin, and core business profitability before interest and taxes.

💜 STIM Gross Profit

Analyze gross margin, pricing power, and profitability before operating expenses.

View Full STIM Report Find More Quality Stocks
Scroll to Top